FDA Approved: IYUZEH — Supplemental Application (Thea Pharma Inc.)

View source ↗

Summary

FDA approves a supplemental application for IYUZEH (latanoprost ophthalmic solution 0.005%). This approval expands the product's labeling related to glaucoma in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• IYUZEH (LATANOPROST OPHTHALMIC SOLUTION 0.005%)

Snippet

SUPPL AP for IYUZEH (LATANOPROST OPHTHALMIC SOLUTION 0.005%)